Evaxion Biotech (EVAX) Tops Q2 EPS by 10c

Evaxion Biotech (NASDAQ: EVAX) reported Q2 EPS of ($0.20), $0.10 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
• Six Flags names Mark Pauls as chief operating officer